Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids - A new disorder

被引:40
作者
Abraham, SC
Carney, JA
Ooi, A
Choti, MA
Argani, P
机构
[1] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Kanazawa Univ, Sch Med, Dept Pathol, Kanazawa, Ishikawa 920, Japan
[3] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
关键词
gastric carcinoids; ECL cell hyperplasia; ECL cell dysplasia; acid secretion; parietal cells;
D O I
10.1097/01.pas.0000163363.86099.9f
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We describe a 54-year-old woman who had multiple gastric carcinoid tumors arising in the setting of marked hypergastrinemia associated with a lack of acid production by hypertrophic parietal cells. The serum gastrin level was 1,400 pg/mL, and investigation revealed no evidence for either of the recognized causes for hypergastrinemia-associated carcinoids, autoimmune gastritis, and Zollinger-Ellision syndrome. Partial gastrectomy was performed. Pathologic examination showed multiple intramucosal and invasive carcinoid tumors of the body and fundus in a background of marked ECL cell hyperplasia. There were no gastric or duodenal ulcerations. One perigastric lymph node was metastatically involved. The oxyntic mucosa showed marked hyperplasia and hypertrophy of the parietal cells. Some of these cells were vacuolated, and many displayed protrusions of apical cytoplasm into dilated oxyntic glands filled with inspissated eosinophilic material. Similar findings have occurred in I other patient, strongly indicating that the clinicopathologic alterations in the 2 cases are not random but, on the contrary, represent a very rare disorder of gastric carcinoids associated with an intrinsic acid secretion abnormality of the parietal cells.
引用
收藏
页码:969 / 975
页数:7
相关论文
共 30 条
  • [1] Bordi C, 1997, J PATHOL, V182, P339, DOI 10.1002/(SICI)1096-9896(199707)182:3<339::AID-PATH854>3.0.CO
  • [2] 2-V
  • [3] BORDI C, 1995, AM J SURG PATHOL, V19, pS8
  • [4] Bordi C, 1998, YALE J BIOL MED, V71, P273
  • [5] FUNDIC ARGYROPHIL CARCINOID-TUMOR IN A PATIENT WITH SPORADIC-TYPE ZOLLINGER-ELLISON SYNDROME
    CADIOT, G
    VISSUZAINE, C
    POTET, F
    MIGNON, M
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (06) : 1275 - 1278
  • [6] Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment
    Cats, A
    Schenk, BE
    Bloemena, E
    Roosendaal, R
    Lindeman, J
    Biemond, I
    Klinkenberg-Knol, EC
    Meuwissen, SGM
    Kuipers, EJ
    [J]. HUMAN PATHOLOGY, 2000, 31 (06) : 684 - 690
  • [7] The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids
    Debelenko, LV
    EmmertBuck, MR
    Zhuang, ZP
    Epshteyn, E
    Moskaluk, CA
    Jensen, RT
    Liotta, LA
    Lubensky, IA
    [J]. GASTROENTEROLOGY, 1997, 113 (03) : 773 - 781
  • [8] Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia
    Eissele, R
    Brunner, G
    Simon, B
    Solcia, E
    Arnold, R
    [J]. GASTROENTEROLOGY, 1997, 112 (03) : 707 - 717
  • [9] ARGYROPHIL CELL HYPERPLASIA AND A CARCINOID-TUMOR IN THE STOMACH OF A PATIENT WITH SPORADIC ZOLLINGER-ELLISON SYNDROME
    FEURLE, GE
    [J]. GUT, 1994, 35 (02) : 275 - 277
  • [10] GODWIN JD, 1975, CANCER, V36, P560, DOI 10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO